top of page

The 2026 Nobel Prize in Medicine Explained: A Light Switch for Brain Cells

Nobel season is our favourite week of the year. Six announcements, six chances to watch the world agree for a moment that evidence matters.


On Monday 5 October 2026, Karl Deisseroth, Peter Hegemann, and Georg Nagel won the Nobel Prize in Medicine for their discoveries concerning light-gated ion channels and optogenetics (1).


Karl Deisseroth, Peter Hegemann, Georg Nagel: Nobel Prize 2026 in Medecine
Karl Deisseroth, Peter Hegemann, Georg Nagel: Nobel Prize 2026 in Medecine

To be simple, they gave science a light switch for individual brain cells. Shine blue light and a chosen type of neuron fires. Shine yellow light on a different protein and the neuron goes silent. The response comes within milliseconds, in a living, moving animal.


Light switch for brain cells (created by AI)
Light switch for brain cells (created by AI)


I trained as a physical and analytical chemist. The first lesson of my discipline is the distance between a signal and a cause. This prize rewards the people who closed that distance for the brain. Most sustainability reports I read have not started.


Below, I explain the science in plain words. Then I hold it next to the way companies run CSR as a business model.


Decades of watching

Before explaining what this Nobel Prize is all about, let's agree on the definition of these two concepts:


Correlation

A correlation means two things change together.


Causation

Causation means changing one makes the other change.


Ice cream sales and drownings rise together every summer.

Nobody bans ice cream to save swimmers, because a third factor, hot weather, drives both.


For most of modern neuroscience, researchers recorded the brain with four main tools:

  • Electrodes that record electrical activity,

  • Brain imaging,

  • Lesions that destroy an area, and

  • Drugs told them which areas lit up during fear, memory or movement.


According to The Nobel Committee, these methods established correlations between brain activity and perception, movement, emotion and cognition (2). Each tool hits a limit before it reaches cause.


Recording and imaging only watch. A scan shows the amygdala active while a person feels fear. That activity might produce the fear, follow from it, or run alongside it, driven by something else. Watching does not tell you which.


Lesions and drugs intervene, but bluntly. Destroy an area and the behaviour disappears, yet that area holds many cell types mixed together, and the lesion removed all of them. A drug spreads to many cell types as well, and it acts far slower than neurons, which signal in thousandths of a second. Researchers learned that something in the region mattered. Which cells, and at which moment, stayed out of reach.


Take your electricity bill. Your smart meter shows a spike every evening at seven. The meter will not tell you whether the oven, the heat pump or the gaming PC in your son’s bedroom caused it. You find out one way. You switch off one appliance at a time and watch the number.


Neuroscientists had no such switch. Neurons of different types sit packed together, and neighbouring cells often drive opposite functions. Francis Crick wrote in 1999 that the ideal tool to control them would be light, and called his own idea "rather far-fetched" (3).


Francis Crick
Francis Crick

The answer came from algae

Chlamydomonas is a green alga made of a single cell, and it swims toward light.

In 1991, Peter Hegemann and his colleague Harald Harz measured the tiny electric current (4) that starts that swim. It switched on within millionths of a second after a flash of light. Cells usually pass a signal along a chain of chemical steps, and chains take time. Hegemann concluded there was no chain. One single molecule had to catch the light and let the current through.


Georg Nagel proved it. In 2002 and 2003, he took the algae gene for that molecule and placed it in frog eggs and in human kidney cells grown in the lab. When the team shone light on those cells, an electric current flowed. One molecule did both jobs: it sensed the light and opened a gate in the cell wall for electric charge. The team named it channelrhodopsin (5,6).


Brain cells talk to each other with electric signals. In 2005, Karl Deisseroth’s team at Stanford put the algae gene into rat brain cells grown in a dish. Blue light made the cells fire on command, one signal per flash, as fast as the light blinked (7).


Earlier teams tried lasers and dyes (2), which damaged the cells. Others built systems from several genes at once, and those reacted too slowly to keep up with a brain signal. The 2005 success then hung on a small detail. This algae molecule needs a helper, retinal, a form of vitamin A, to catch light. Nagel noticed that brain cells already carry enough of it, so nobody had to inject any (7).


Count the years. The algae measurement came out in 1991. The Nobel call came in 2026. That is 35 years of research on pond algae with no product and no revenue line. How many projects in your R&D budget would survive 35 years of that?


What the switch revealed


Once researchers held a switch for specific cells, the brain stopped looking like a set of regions and started looking like a set of circuits. Three results matter for anyone who runs an organisation.


  • In 2012, Stephan Lammel, Karl Deisseroth, Robert Malenka and colleagues showed that dopamine neurons in the same small brain region drive opposite states, reward in one case and aversion in the other, depending on which inputs reach them (8).

  • In 2013, Steve Ramirez and colleagues in Susumu Tonegawa’s laboratory at MIT created a false memory. Mice froze in fear in a room where nothing bad had ever happened to them (9).

  • In 2021, José-Alain Sahel, Botond Roska and colleagues reported that a blind patient with retinitis pigmentosa, treated with an optogenetic gene therapy and engineered goggles, regained enough vision to locate high-contrast objects on a table. The result covers one patient and partial vision, after decades of work. Several clinical trials are now under way (10, 2).


Hold your CSR report up to the same light

Companies have the brain’s old problem. Activity shows up everywhere, and causes show up nowhere on the dashboard. Here is the comparison, level by level.


People

An annual engagement survey records the whole organisation at once, the way an electrode on the scalp records the whole brain. Scores drop in one department. The cause sits somewhere among the manager, the shift pattern, the pay grid and the open-plan floor, and the survey will not say where.


The Lammel result applies here. Two teams on the same floor respond in opposite directions to the same policy. A company-wide wellbeing programme averages them into a flat line.


Which of your People initiatives have you ever switched off at one site and kept at another, to see what changed?


Planet

The environmental disclosure platform, found in 2021 that supply chain emissions average 11.4 times a company’s own operational emissions (11).


In a 2023 report, approximately 41% of responding companies disclosed at least one category of those supply chain emissions (12).


Run the arithmetic for an average company.

Operational emissions equal 1 unit, supply chain emissions equal 11.4 units, total equals 12.4.

A report that covers operations alone covers approximately 8% of the footprint.


Pre-2005 neuroscience recorded the surface of the skull. The Planet equivalent is a carbon report that stops at the factory gate. Which supplier category would you target first if you had to prove a reduction, not estimate one?


Profit

Optogenetics answers two questions about any cell.

Switch it on: is it sufficient to produce the behaviour?

Switch it off: is it necessary?


Apply the same two tests to each line of your CSR budget.

Turn the programme off.

Does revenue move, does risk move, does anyone outside the communications team notice?


The Ramirez experiment has a commercial twin.

Greenwashing plants a memory of virtue in customers who never saw anything green happen.

The European Union has noticed. Directive (EU) 2024/825 on empowering consumers for the green transition bans generic environmental claims without recognised proof, and member states apply it from 27 September 2026. Ten days ago, the false memory became a legal liability.


Why optogenetics earned a Nobel Prize

The Nobel Prize in Physiology or Medicine rewards, in the Nobel Assembly’s words, the most important discoveries for the benefit of humankind. For more than a century, brain science watched the brain and guessed at causes. Optogenetics lets researchers test them. They switch a chosen group of cells on and see whether a behaviour appears, then switch it off and see whether it disappears. A guess becomes proof.


The method also left the lab bench of its inventors. Laboratories around the world now use it, as the Nobel Assembly noted on announcement day. It has given one blind patient partial sight, and several clinical trials are now under way. Researchers also hope it will make cochlear implants more precise than today’s electrical devices.


None of it began as a plan to cure anything. A few scientists wanted to know how a single-celled alga finds the light.

Harz and Hegemann published their algae recording in Nature in 1991. Thirty-five years later, Stockholm called.


Conclusion


This prize completes a pattern.

  • 2023, mRNA (Karikó and Weissman): messenger RNA delivers instructions to make a protein on demand. Their key finding was a small chemical change to the RNA that switches off the immune system's false alarm against it. Without that change, the vaccine triggers inflammation. With it, the instruction gets through.

  • 2024, microRNA (Ambros and Ruvkun): tiny RNA molecules silence specific genes. Every cell carries the same DNA, and microRNAs decide which instructions a muscle cell ignores and which a brain cell ignores.

  • 2025, regulatory T cells (Sakaguchi, Brunkow and Ramsdell): these cells and the Foxp3 gene act as brakes on the immune system. Remove the brake and the body attacks itself, causing autoimmune disease.

  • 2026, optogenetics (Deisseroth, Hegemann and Nagel): a light-triggered switch that turns chosen neurons on or off within milliseconds.


Companies invest heavily in growth engines and rarely in their own off switches. Few have a governance mechanism that stops a programme when evidence shows it fails, or a brake that catches a strategy before it damages the business.

Four Nobel committees in a row rewarded control systems, while most boards still reward expansion.




bottom of page